{
  "node_id": "fda-pdufa-vii-goals-letter-2022",
  "title": "FDA PDUFA VII Performance Goals and Procedures 2023-2027",
  "domain": "Pharmaceuticals & Life Sciences",
  "version": "1.0.1",
  "last_updated": "2026-04-30",
  "bluf": "The FDA PDUFA VII requires prescription drug manufacturers to meet specific performance goals and procedures for the review of new drug applications, as outlined in Section 735(1) of the Federal Food, Drug, and Cosmetic Act.",
  "paywall": {
    "status": "LOCKED",
    "unlock_cost_usd": "0.01",
    "skyfire_id": "41779894-ece2-4163-9761-b3b1b76e19b0"
  },
  "crosswalks": {
    "_available_keys": [
      "nist_framework",
      "iso_standard",
      "industry_mapping",
      "ai_overlay_2026"
    ],
    "_note": "Full crosswalk values included in vault response"
  },
  "dependencies": [
    "iso-37301-compliance-2021"
  ],
  "primary_citations_count": 6
}